Ponatinib: A third-generation inhibitor for the treatment of CML

Julius Wehrle, Nikolas von Bubnoff*

*Corresponding author for this work
5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ponatinib: A third-generation inhibitor for the treatment of CML'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science